Background/Aims: Hypertrophic scars (HS) formation results from reduced apoptosis and increased proliferation of fibroblasts. Therefore, apoptosis of fibroblasts is a key target for the development of novel therapeutic strategies for HS. Previous reports demonstrated that FK506 could attenuate scar formation in vivo and FK506 could also induce endoplasmic reticulum stress (ER stress). However, the effects of FK506 on ER stress-mediated apoptosis in fibroblasts remain unclear. Methods: Rat skin fibroblasts were used in the study. Cell viability was examined using cell counting Kit-8. Apoptosis was detected by Annexin V/Propidium Iodide Double Staining. Gene silencing was performed using Small Interfering RNAs (siRNAs) or via lentiviral infection. The expression of apoptosis-related proteins was determined via Western blot. Interaction between proteins was explored by co-immunoprecipitation. Results: FK506 significantly reduced cell viability and induced apoptosis in fibroblasts. Interestingly, ER stress was also activated after FK506 treatment. We further demonstrated that FK506-induced apoptosis was mediated by ER stress via activating CHOP, evidenced by decreased apoptosis after inhibition of ER stress using TUDCA or silencing expression of CHOP. Furthermore, Co-immunoprecipitation results indicated that treatment of FK506 induced disassociation of FKBP12.6 from RyR2 and its translocation from ER membrane to cytosol, consequently promoting ER stress-mediated apoptosis. Conclusion: FK506-induced fibroblasts apoptosis was mediated by ER stress via CHOP signaling pathway.
ER Stress via CHOP Pathway is Involved in FK506-Induced Apoptosis in Rat Fibroblasts
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Introduction
Hypertrophic scars (HS), a pathological process response to wound healing which generally occurs following surgery, trauma and burns, often caused severe impairment to patients. Although the pathological mechanisms concerning HS formation remain elusive. It has been demonstrated that HS formation results from the reduced apoptosis consequently, increasing proliferation of fibroblasts [1] . Therefore, apoptosis of fibroblasts is a key target for the development of novel therapeutic strategies for HS.
The endoplasmic reticulum (ER) is a cellular organelle, where the majority secreted, glycosylated, and lipid proteins are folded into their proper tertiary and quaternary structures. The conditions of imbalance of Ca 2+ homeostasis and protein overload in the ER could lead to accumulation of unfolded proteins, which resulted in ER stress or unfolded protein response (UPR). [2, 3] Normally, proteins are held in inactive states in ER membranes. In response to stimuli of overload misfolded proteins, IRE1, PERK and ATF6 initiate signals to promote the expression of genes required for folding of newly synthesized proteins and/ or for degradation of unfolded proteins to reconstruct homeostasis and normal ER function. However, when injury is too excessive, these same ER stress signal transduction pathways can also induce cell death. [4, 5] Therefore, ER stress also plays a key role in apoptosis. [6] [7] [8] FK506, an immunosuppressive agent, has been widely demonstrated to possess various biological activities, such as anti-inflammatory, anti-angiogenic and anti-tumorigenic properties [9] [10] [11] . Importantly, in our previous studies, we found that FK506 attenuated the scar formation in sciatic nerve-injured rat and FK506 also involved in ER stress pathway [12] . In this study, we investigated the effects of FK506 on the apoptosis of rat fibroblasts and found that FK506 induced rat fibroblasts apoptosis through activating ER stress.
Materials and Methods

Rat skin fibroblasts isolation and culture
Fibroblast cultures were prepared from the post-natal day-1 Sprague-Dawley rats dorsal skin as described previously with minor modifications [13] . Briefly, each biopsy was minced with sterile scissors and treated with 0.06 mg/ml collagenase I (Sigma, St. Louis, MO) in α-MEM at 37°C for 1.5 h (mixing every 30 min). The digest was then strained into a 50-ml tube containing 5 ml of ice-cold α-MEM supplemented with 20% fetal bovine serum (FBS; Gibco, USA) (termed fibroblast isolation medium) on ice through a 70-μm nylon strainer (BD Falcon, Bedford, MA). Remaining tissue was further digested in 1 mg/ml trypsin (Sigma) at 37°C for 30 min (mixing every 10 min). Digestion was stopped by adding an equal amount of fibroblast isolation medium, and the cells were strained into the same tube. After centrifugation, the cell pellet was resuspended and cultured at 37°C under 5% CO2 in Dulbecco's modified Eagle's medium (DMEM; Gibco, USA) with Lglutamine (2 mM), 10% fetal bovine serum (FBS; Gibco, USA), penicillin (100 IU/ml), and streptomycin (100 mg/ml) (Thermo, USA). Cells in exponential growth phase between passages 4 and 7 were used for all experiments.
FK506 Treatment
A fibroblast monolayer seeded in 24-well plates or 10 cm dishes overnight and was washed with phosphate-buffered saline (PBS; pH 7.4) , then subjected to FK506 (Sigma, St. Louis, MO) with various doses (0,10,20,40,80 and 160μM, dissolved in DMSO and then diluted in PBS) and times (0, 4, 8, 12, 24 and 48h). The control groups were treated with PBS alone. After treatment, the cells were immediately washed three times with PBS and maintained in growth medium for subsequent experiments.
Cell Viability Assay
Cell viability was determined using the Cell Counting Kit-8 (CCK-8) (Dojindo Laboratories, Kumamoto, Japan) according to the manufacturer's instructions. Fibroblasts were plated in 6 replicates in 96-well plates (100 ml, 2x10 3 /well). After plating (24 hours), the cells were subjected to various treatments. The CCK-8 solution (10 ml) was added to each well, and the cells were incubated for another 3 hours at 37°C, after which the optical density was measured at 450 nm using a microplate absorbance reader (Bio-Tek, Elx800, USA). Cells that stained positively with the CCK-8 solution were considered viable and are presented as a percentage compared with control cells.
Cell Death Assay
For cell death assays involving FK506, fibroblasts were pretreated with or without TUDCA (500 μg/ ml) for 48 h, with Z-YVAD-FMK (25 μM) for 1 h, with 3-methylademine (3-MA) and necrostatin-1 for 8 h followed by treatment with FK506 (80μM) for 24h. For quantification of cell death, cells were trypsinized and stained with trypan blue followed by counting with a haemocytometer using standard protocol. Cells stained blue were considered as dead cells. Quantification of cell death was further confirmed by propidium iodide staining followed by FACS analysis.
Gene Silencing Using Small Interfering RNAs (siRNAs) or via Lentiviral Infection
Fibroblasts were plated in 60-mm wells and allowed to reach 50% confluence at the time of transfection. CHOP and nontargeting control siRNAs were purchased from Santa Cruz Biotechnology. Cells were transfected with 100 nM concentrations of siRNAs diluted in Opti-Eagle's minimal essential medium (MEM) using Lipofectamine 2000 (Invitrogen, USA), according to the manufacturer's instructions. The cells were treated with FK506 at 48 hours post-transfection for subsequent experiments. Lentiviral vectors that contained target genes including PERK (Target sequences: CACAACTGTATAACCGTTA), IRE1 (Target sequences: ACCAAGGGAGAACCAGGAAACG), and ATF6 (Target sequences: TTCTGGACGGGCTTCATAGTAGAC) were purchased from Shanghai Genechem Co. Ltd. (Genechem, China). Lentiviral infection was carried out according to the manufacturer's instructions. Fibroblasts were incubated in growth media with the lentiviruses at an MOI of 20 in the presence of 2 mg/ml polybrene (Gibco, USA) overnight, after which the medium was removed, and fresh complete medium was added. Following transfection (48 hours), the cells were grown in culture with 2 mg/ml puromycin (Sigma, USA) for at least 96 hours to select for stably transfected cells for subsequent experiments.
Acquisition of cytosol fraction and ER membrane fraction by subcellular fractionation
The method of subcellular fraction isolation was in accordance with previous studies [14] . Cells were homogenized in isolation buffer containing 0.29 mmol/L sucrose, 3 mmol/L imidazole, 1 mmol/L benzamidine, 0.5 mmol/L phenylmethanesulfonyl fluoride, 2 μg/ml pepstain A, 2 μg/ml leupeptin and 2 μg/ ml aprotinin. Then cells were transferred into lysis buffer containing 50 mmol/L HEPES, 25 mmol/L Tris, 2.5 mmol/L dithiothreitol, 0.5% soya-bean phosphatidylcholine, 1% 3-[3-(cholamidopropyl) dimethylammonio]-1-propanesulfonic acid, 1 mmol/L benzamidine, 0.5 mmol/L phenylmethanesulfonyl fluoride, 2 μg/ml pepstain A, 2 μg/ml leupeptin and 2 μg/ml aprotinin. After centrifugation at 16,000 g twice at 4°C for 30 min, the total cell lysate was collected. The collected cell lysate was then centrifuged at 1000 g at 4°C for 20 min, and then the resulted pellet was homogenized and further centrifuged at 27,000 g at 4°C for 15 min. Then the resulted supernatant was further centrifuged at 100,000 g at 4°C for 15 min. The resulted supernatant was cytosol fraction while the resulted pellet could be collected as ER membrane fraction.
Intracellular Ca
2+ Measurement After washing twice with PBS, the adherent fibroblasts were digested from plates with 300 μl 0.25% trypsin per well, and then quenched by the addition of Ca
2+
-free medium containing 900 μl 10% FBS per well. The suspensions were collected and centrifuged at 1000 rpm for 10 mins. After discarding the supernatant, cells were suspended with Ca
-free PBS and incubated in dark with 1uM Fluo-3AM (Beyotime Biotechnology, Shanghai, China) at 37°C for 20 mins. The sample without Fluo-3AM was considered as the blank control. Before detection, cells were washed twice with PBS to minimize background fluorescence and nonspecific staining. The fluorescence was measured at an emission wavelength of 530 nmin a flow cytometer (Becton Dickinson, FACSCalibur-E4121, California, USA) with an excitation laser at 488 nm, and at least 10,000 events per sample were acquired. Images were analyzed with Image J software (National Institutes of Health) and the mean fluorescence intensity (Integrated intensity/Area) was measured to represent relative intracellular Ca 2+ concentrations. Also, Fluo-3AM positive cells counting was performed by flow cytometer.
Immunoprecipitations
Cells were lysed in 100µl of RIPA buffer and incubated on ice for 30 min followed centrifugation (13,000 rpm, 1hr at 4°C) and incubated in BSA blocked 1.5mL microcentrifuge tubes with RyR2 antibody (purchased from Abcam) and protein G-agarose beads (Thermo Scientific) overnight at 4°C. Beads were washed in RIPA buffer then heated for 8 minutes at 100°C in 60µl of SDS sample buffer. Samples were centrifuged at RT for 3 min at 13,000 rpm and the supernatant was run on 10% SDS-PAGE for analysis.
Western Blot Analysis
Fibroblasts were lysed on ice in lysis buffer (Beyotime, Hangzhou, China) according to the manufacturer's instructions, and the lysates were centrifuged at 14,000 g at 4°C for 15 minutes. Proteins were extracted from total fibroblasts lysate, ER membrane fraction and cytosol fraction respectively. For detection of ATF6, nuclear extracts were prepared using a nuclear extract kit (Active Motif, Belgium) according to manufacturer's instructions. Lamin C was used as a control for equal nuclear protein loading. The protein concentration was determined using the BCA Protein Assay Kit (Thermo, USA). Equal amounts (25 μg/ lane) of total protein were subjected to electrophoresis in a 10% SDS-polyacrylamide gel. Following electrophoresis, the proteins were electro-transferred to polyvinylidene difluoride membranes (Millipore, USA). The membranes were then blocked with 5% skim milk in TBST at room temperature for 2 hours and subsequently incubated with primary antibodies (diluted 1:500 to 1:1,000) at 4°C overnight. Anti-78-kDa glucose-regulated protein (GRP78), anti-CHOP, anti-PERK, anti-phospho-PERK, anti-eukaryotic translation initiation factor 2a (eIF2a), anti-phospho-eIF2a (phospho S51), anti-BAX, and anti-BCL-2 antibodies were obtained from Cell Signaling Technology (Cell Signaling Technology, USA). An anti-β-actin antibody was obtained from Santa Cruz Biotechnology (Santa Cruz Biotechnology, USA). Anti-activating transcription factor 6 (ATF6), anti-inositol-requiring enzyme 1a (IRE1a), anti-phospho-IRE1a (S724), anti-Sigma-1, and anti-FKBP12.6 antibodies were purchased from Abcam (Abcam, USA). The membranes were next washed three times in TBST and incubated with horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit IgG (Santa Cruz Biotechnology, USA) (diluted 1:5,000) for 1 hour. The immune complexes were visualized via fluorography using an enhanced ECL system (Millipore, USA).
Annexin V/Propidium Iodide Double Staining
Annexin V/propidium iodide double staining was used to detect apoptosis. Fibroblasts were plated in 60-mm dishes (3 ml, 1*10 6 /well) and incubated for 24 hours at 37°C. After treatment, the cells were collected and washed twice with ice-cold PBS and then resuspended and incubated with Annexin V-FITC and propidium iodide (BD Biosciences, USA) to achieved double staining, according to the manufacturer's instructions and analyzed using the Beckman Coulter FC500 flow cytometry system and CXP software (Beckman Coulter, Fullerton, CA).
Statistical Analysis
Data are presented as the mean±SD of triplicate experiments. Significant differences among treatment groups were analyzed via one-way ANOVA, followed by a Dunnett test or Student's t-test using SPSS (Statistical Package for the Social Sciences) 13.0 software. Statistical significance was defined as a P value<0.05.
Results
ER stress plays a key role in FK506 induced rat skin fibroblast apoptosis
We initially examined the effect of FK506 on fibroblasts. Cells were exposed to various concentrations (0-160μM) of FK506 for 24 hours. Additionally, cells were treated with 80μM FK506 for different time periods. CCK-8 assays were performed to confirm the effect of FK506 on fibroblast viability. As shown in Figure 1 , FK506 induced a decrease in fibroblast viability in a dose-and time-dependent manner. A marked reduction in cell viability was observed at 24 hours after treatment with FK506 at a dose of 80μM. To confirm the mode of FK506-induced cell death, we treated cells with TUDCA, a specific inhibitor of ER stress. Notably, TUDCA almost completely rescued cell death in fibroblasts. In contrast, inhibitors of cell death via other pathways, including 3-MA (3-methylademine, autophagy inhibitor), Z-VAD-FMK (apoptosis inhibitor) and necrostatin-1(necroptosis inhibitor), failed to suppress FK506-induced cell death (Fig. 1C) . Similar results were observed using trypan blue assay (Fig. 1D) and Annexin V/propi dium iodide double staining. (data not shown). These results suggested that treatment with FK506 increased fibroblast apoptosis via ER stress pathway.
FK506 induced ER stress in rat skin fibroblasts
To further demonstrate whether ER stress pathway is involved in the process of FK506-induced fibroblasts apoptosis, we explored expression of GRP78, a key marker for ER stress detection. Western blot revealed significant upregulation of GRP78 after treatment of FK506, 2 . Kinetics of three UPR sensors in rat skin fibroblasts. A. Western blot analysis of GRP78, p-PERK, p-eIF2α, CHOP, p-IRE-1, ATF6 in FK506 (80μM) treated rat fibroblasts, and β-actin or Lamin C was used as loading control. B. Results were expressed as relative intensity of GRP78/β-action, p-PERK/PERK, p-eIF2α/ eIF2α, p-IRE-1/IRE-1, CHOP/β-action, ATF 6/Lamin C, respectively. *p<0.05 vs. 0h.
indicating that ER stress was remarkably induced. To gain more insight into the molecular effects of FK506, we investigated the effects of FK506 on three ER stress transducers (IRE1, PERK and ATF6). Results showed that all three pathways were activated in a time-dependent manner within 24 hours of treatment with 80μM FK506. Regarding time-dependent kinetics, we observed a marked increase in phospho-IRE1 at 4 hours after treatment, which was sustained for the next 8 hours, and then declined to the initial level. These data indicated that the IRE1 pathway is temporarily induced by FK506 treatment. In addition, we also found that ATF6 in nuclear extracts markedly increased significantly after FK506 treatment, indicating remarkable translocation of spliced ATF6 from ER membrane to nucleus. However, the PERK pathway exhibited a distinctive feature. Western blot analysis showed that the levels of PERK, eIF2α, and CHOP increased with increasing time after treatment (Fig. 2) . Taken together, these results led us to conclude that ER stress is induced by FK506 in rat skin fibroblasts.
Attenuation of FK506-induced apoptosis by suppression of CHOP
To further investigate which pathway play a pivotal role in FK506-induced ER stress associated with apoptosis, we used lentiviral-mediated shRNAs to downregulate the expression of the three major ER stress sensors: PERK, IRE1, and ATF6. We also used siRNA to downregulate CHOP expression, which is well known involving in apoptosis during ER stress. Lentiviruses and siRNA that downregulated the three transducers and CHOP strongly decreased the expression of the corresponding proteins in fibroblasts (Fig. 3A) . Annexin V/propidium iodide double staining demonstrated that FK506 induced 19.89% apoptosis in the scramble control group, whereas 9.82% of the cells in the PERK knockdown group, 10.33% of the cells in the ATF 6 knockdown group, 17.3% of the cells in the IRE1 knockdown group, and only 4.6% of the cells in the CHOP knockdown group were apoptotic (Fig. 3B) . The levels of CHOP and its downstream Bcl-2 and Bax were detected by Western blotting at 24 hours after FK506 treatment. Decreased CHOP was detected in the PERK and ATF 6 knockout group (Fig. 3C ). These observations suggest that CHOP is downstream of PERK and ATF 6, rather than the IRE1 pathway examined here. Decreased expression of CHOP accompanied with increased Bcl-2 and decreased Bax levels (Fig. 3C) . Taken together, these data suggested that CHOP plays a crucial role in FK506-induced fibroblasts apoptosis.
FK506 triggered ER stress via inducing excessive Ca
2+ influx We further explored the molecular mechanism in which ER stress was activated by FK506. Numerous evidence have demonstrated that intracellular calcium overload is a key stimulator in ER stress. Given this, we detected intracellular Ca 2+ concentrations in fibroblasts at different time points (15 min, 30 min, 1 h, 2 h, and 4 h) after treatment with FK506. To measure intracellular Ca 2+ concentration, cells were incubated with Fluo-3AM probes and detected by FACS analysis. Results showed that fluorescence intensity in 
FK506 induced FKBP12.6 disassociation from RyR2 and translocation from ER membrane to cytosol
The disassociation of FKBP12.6 from RyR2 may lead to increase RyR2 activity and then calcium would be excessively released from ER to increase intracellular calcium concentration which was reportedly involved in the ER stress. Western blot results in Figure  5A indicate that the translocation of FKBP12.6 from ER membrane to cytosol was augmented after FK506 treatment compared with control. In this study, the association of FKBP12.6 and RyR2 was evaluated by co-immunoprecipitation assay which is demonstrated in Figure 5B . Evidenced by this analysis, the association of FKBP12.6 and RyR2 was dramatically impaired in FK506 treatment compared with controls.
Discussion
FK506, used for immunosuppressive maintenance therapy following organ transplantation, has well documented cytotoxic effects on several cells such as beta cells, T cells and MRC-5 cells by increasing cleaved caspase-3 levels [15] [16] [17] . Here we report for the first time that FK506-induced apoptosis in rat skin fibroblasts. Specifically, we demonstrated that treatment with FK506 led to a significant increase in fibroblasts death in a dose-and time-dependent manner, and this increase of cell death is due to ER stress pathway. Notably, FK506-induced fibroblasts apoptosis was accompanied by the activation of ER stressresponsive elements, and the increase in apoptosis was attenuated by CHOP deletion. The PERK and ATF6 are required for CHOP activation and involved in CHOP mediated apoptosis. Furthermore, we found that FK506-induced ER stress was triggered by Ca 2+ influx. The reduced association of FKBP12.6 and RyR2 might be expected to impair ER Ca 2+ homeostasis. This latter impairment may lead to ER stress.
Mammalian cells exhibit intrinsic and extrinsic pathways of apoptosis. In the intrinsic or mitochondrial pathway, the B-cell lymphoma-2 (Bcl-2) family of proteins has a crucial role. In the extrinsic pathway, ligand stimulation of the death receptors incites apoptosis. These are members of the tumor necrosis factor receptor (TNFR) family, such as Fas, which have an intracellular death domain [18] [19] [20] [21] [22] [23] . In present study, FK506 induced fibroblast apoptosis competitively inhibited by TUDCA, a specific ER stress inhibitor. In competition assays, Z-YVAD-FMK (caspase mediated apoptosis inhibitor), 3-MA (autophagy inhibitor), and necrostatin-1(necroptosis inhibitor) failed to suppress FK506-induced cell apoptosis. These results revealed that the potential mechanism of FK506 induced rat skin fibroblast apoptosis was caused by ER stress differing from other cells. Otherwise, cytotoxic effect on fibroblasts was detected only in high concentration FK506 treatment in agreement with previous findings [17] .
The up-regulation of 78-KDa glucoseregulationed protein (GRP78) has been widely used as a key marker for ER stress. ER stress initiates the unfolded protein response (UPR) when multiple factors disturb protein folding and cause the accumulation of unfolded proteins in the ER. When ER stress happens, accumulative unfolded proteins make the dissociation of GRP78) from three types of ER membrane receptors (ER stress sensors), PERK, ATF-6 and IRE-1. [24] [25] [26] [27] [28] Our results suggested that FK506 treatment time-dependently increased the expression levels of p-PERK and its downstream p-eIF2α, CHOP, p-IRE-1, ATF-6 and GRP78 in rat skin fibroblast. So, our findings demonstrated that FK506 could trigger fibroblast UPR by PERK, IRE-1and ATF-6 signal pathways.
Excessive ER stress could result in a failure of UPR-mediated adaptive mechanisms to compensate for the augmented demands of protein folding, thus triggers apoptotic programs [29, 30] . CHOP, ER stress-induced transcription factor, is an important regulator of apoptosis in response to ER stress and it can be activated by all the three UPR signaling pathways [31, 32] . However, our results suggested it is highly likely that FK506 induced apoptosis via the PERK, ATF6 signal pathways. Firstly, deleted CHOP almost completely attenuated the increase of apoptosis induced by FK506. But deletion of PERK and ATF 6 only partially attenuated this increase. In contrast, there is no effect of IRE-1 deletion on FK506 induced apoptosis. Furthermore, deletion of PERK and ATF 6 decreased the expression of CHOP in FK506 treated fibroblasts. However, IRE-1 deletion did not affect the CHOP expression. One of the mechanisms of CHOP-mediated apoptosis is that CHOP can regulate the expression of Bcl-2 protein family by down-regulating the expression of Bcl-2 and facilitating the translocation of proapoptotic protein Bax [33] [34] [35] . In agreement with previous findings, our two external observations demonstrate that FK506-induced apoptosis in fibroblast is mediated by downregulation the expression of Bcl-2. Firstly, the absence of the PERK and ATF 6 decreased the apoptosis rate in FK506 treated fibroblasts, accompanied with an increase of Bcl-2 and a decrease of Bax expression. Secondly, pan-caspase substrate tripeptide Z-YVAD-FMK did not affect the cell death in FK506 treated cells.
The ER lumen is the major storage of intracellular Ca 2+ and Ca
2+
-binding chaperones. Ca 2+ trafficking in and out of the ER regulates a diversity of cellular responses and signaling transduction pathways [36, 37] . Ca 2+ signaling may occur in the form of local Ca 2+ release events due to the synchronized opening of a cluster of ryanodine receptors (RyRs), the main intracellular Ca 2+ release channels on the reticulum [38, 39] . Under physiological conditions, FKBP12.6 (FK506-binding protein) binds to RyR to form FKBP-RyR complex with low RyR channel activity. The disassociation of FKBP12.6 from RyR2 facilitates increasing activity of RyR2 and then lead to Ca 2+ releasing from ER to cytosol, which would trigger ER stress [40, 41] . Our results showed a decreased association between FKBP12.6 and RyR2 under FK506 treatment. Further, the augmented translocation of FKBP12.6 from ER membrane to cytosol also confirmed this decreased association. Thus, promoting disassociation of FKBP12.6 from RyR2 could be the possible mechanisms of FK506 induced ER stress in fibroblasts.
Limitations also existed in the present study. We only performed in-vitro experiments to demonstrate the effects of FK506 on fibroblasts apoptosis and the potential molecular mechanism. Further in-vivo studies were also required to investigate the effects of FK506 in the process of HS. In addition, as a kind of immunosuppressant, FK506 has a certain side effects in multiple organs of humans, which should not be ignored before clinical application. Hence, further investigations may focus on exploring the proper dosage, which can reduce formation of HS with side effects as little as possible. Moreover, it's important to note that cell apoptosis is rather complicated, various mechanisms and pathways participate in this process. In our study, we only verified that ER stress was indeed involved in the process of FK506-induced fibroblasts apoptosis, however, did not exclude other possible mechanisms and pathways.
Taken together with current study, we confirmed that FK506 could activate ER stress and demonstrated that FK506 related ER stress could induce apoptosis in rat skin fibroblasts via CHOP signaling pathway, indicating the potential use of FK506 as a novel treatment modality for HS. 
